Propanc Biopharma, Inc. Quarterly Return On Equity in % from Q3 2012 to Q3 2024

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Propanc Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2012 to Q3 2024.
Propanc Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was 48.2 %, a 39.8% decline year-over-year.
Propanc Biopharma, Inc. annual Return On Equity for 2024 was 51.9 %, a 42.7% decline from 2023.
Propanc Biopharma, Inc. annual Return On Equity for 2023 was 90.6 %, a 4.46% decline from 2022.
Propanc Biopharma, Inc. annual Return On Equity for 2022 was 94.9 %, a 51.2% increase from 2021.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2024	48.2	-31.9	-39.8%	Jul 1, 2024	Sep 30, 2024
Q2 2024	51.9	-38.7	-42.7%	Apr 1, 2024	Jun 30, 2024
Q1 2024	66.1	-30.6	-31.7%	Jan 1, 2024	Mar 31, 2024
Q4 2023	79.1	-5.71	-6.74%	Oct 1, 2023	Dec 31, 2023
Q3 2023	80.1	-15.4	-16.1%	Jul 1, 2023	Sep 30, 2023
Q2 2023	90.6	-4.23	-4.46%	Apr 1, 2023	Jun 30, 2023
Q1 2023	96.8	+6.72	+7.47%	Jan 1, 2023	Mar 31, 2023
Q4 2022	84.8	-3.2	-3.64%	Oct 1, 2022	Dec 31, 2022
Q3 2022	95.5	+25.7	+36.8%	Jul 1, 2022	Sep 30, 2022
Q2 2022	94.9	+32.1	+51.2%	Apr 1, 2022	Jun 30, 2022
Q1 2022	90	+88.8	+6970%	Jan 1, 2022	Mar 31, 2022
Q4 2021	88	+30.3	+52.5%	Oct 1, 2021	Dec 31, 2021
Q3 2021	69.8	-14.7	-17.4%	Jul 1, 2021	Sep 30, 2021
Q2 2021	62.8	-38.7	-38.1%	Apr 1, 2021	Jun 30, 2021
Q1 2021	1.27	-155	-99.2%	Jan 1, 2021	Mar 31, 2021
Q4 2020	57.7	-66	-53.4%	Oct 1, 2020	Dec 31, 2020
Q3 2020	84.5	-42.4	-33.4%	Jul 1, 2020	Sep 30, 2020
Q2 2020	101	-32.7	-24.4%	Apr 1, 2020	Jun 30, 2020
Q1 2020	156	+42.2	+37.1%	Jan 1, 2020	Mar 31, 2020
Q4 2019	124	+10.8	+9.52%	Oct 1, 2019	Dec 31, 2019
Q3 2019	127	+16.5	+14.9%	Jul 1, 2019	Sep 30, 2019
Q2 2019	134	+31.4	+30.6%	Apr 1, 2019	Jun 30, 2019
Q1 2019	114	+2.6	+2.34%	Jan 1, 2019	Mar 31, 2019
Q4 2018	113	-5.72	-4.82%	Oct 1, 2018	Dec 31, 2018
Q3 2018	110	-57.2	-34.1%	Jul 1, 2018	Sep 30, 2018
Q2 2018	103	-96.5	-48.4%	Apr 1, 2018	Jun 30, 2018
Q1 2018	111	-170	-60.5%	Jan 1, 2018	Mar 31, 2018
Q4 2017	119	-218	-64.8%	Oct 1, 2017	Dec 31, 2017
Q3 2017	168	-176	-51.3%	Jul 1, 2017	Sep 30, 2017
Q2 2017	199	-99	-33.2%	Apr 1, 2017	Jun 30, 2017
Q1 2017	281	+25.7	+10%	Jan 1, 2017	Mar 31, 2017
Q4 2016	337	+103	+44.1%	Oct 1, 2016	Dec 31, 2016
Q3 2016	344	+205	+147%	Jul 1, 2016	Sep 30, 2016
Q2 2016	298	+139	+87.1%	Apr 1, 2016	Jun 30, 2016
Q1 2016	256	+152	+146%	Jan 1, 2016	Mar 31, 2016
Q4 2015	234	+143	+158%	Oct 1, 2015	Dec 31, 2015
Q3 2015	139	+62.2	+80.8%	Jul 1, 2015	Sep 30, 2015
Q2 2015	159	+90.8	+133%	Apr 1, 2015	Jun 30, 2015
Q1 2015	104	+24.9	+31.5%	Jan 1, 2015	Mar 31, 2015
Q4 2014	90.7	-25.6	-22%	Oct 1, 2014	Dec 31, 2014
Q3 2014	77	-102	-56.9%	Jul 1, 2014	Sep 30, 2014
Q2 2014	68.5	-138	-66.8%	Apr 1, 2014	Jun 30, 2014
Q1 2014	79.2	-515	-86.7%	Jan 1, 2014	Mar 31, 2014
Q4 2013	116	-22.7K	-99.5%	Oct 1, 2013	Dec 31, 2013
Q3 2013	179	+880		Jul 1, 2013	Sep 30, 2013
Q2 2013	207			Apr 1, 2013	Jun 30, 2013
Q1 2013	594			Jan 1, 2013	Mar 31, 2013
Q4 2012	22.8K			Oct 1, 2012	Dec 31, 2012
Q3 2012	-702			Jul 1, 2012	Sep 30, 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.